Status:
COMPLETED
Double-Blind Study of Miglitol in Japanese With type2 Diabetes
Lead Sponsor:
Sanwa Kagaku Kenkyusho Co., Ltd.
Conditions:
Type 2 Diabetes Mellitus
Eligibility:
All Genders
20-69 years
Phase:
PHASE3
Brief Summary
To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.
Eligibility Criteria
Inclusion
- Type2 diabetic patient on Dietary Therapy
- Criteria for postprandial plasma glucose and HbA1c are met
Exclusion
- Type1 diabetes
- Patients treated with antidiabetic drugs or Insulin
Key Trial Info
Start Date :
Trial Type :
INTERVENTIONAL
End Date :
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00380822
Last Update
September 27 2006
Active Locations (27)
Enter a location and click search to find clinical trials sorted by distance.
1
Aichi, Japan
2
Chiba, Japan
3
Fukuoka, Japan
4
Gunma, Japan